| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Obstetrics and Gynecology (I.G., Y.T., O.C., R.K., M.N., B.C.Y., S.Y., H.M.) and Pediatrics (S.Y.), Yokohama City University School of Medicine, Yokohama 236-8567, Japan
Address all correspondence and requests for reprints to: Itsuo Gorai, Department of Obstetrics and Gynecology, Yokohama City University School of Medicine, 39 Fukuura, Kanazawa-ku, Yokohama 236, Japan.
We examined sequential changes of bone-resorbing cytokines and bone metabolic markers and the effect of ovarian hormones on bone metabolism during the menstrual cycle in 10 healthy Japanese women, aged 2243 yr, with normal ovarian function. Serum soluble interleukin-6 receptor (sIL-6R) showed a significant variation; a rise during the early and late follicular periods followed by a fall during the early luteal period (P = 0.0423, P = 0.0334) and an increase during the mid and late luteal periods. There were significant changes in the levels of markers of bone formation: a rise in serum bone-specific alkaline phosphatase (ALP) during the mid and late follicular (P = 0.0265) periods and a fall in serum carboxyl-terminal propeptide of type I procollagen (PICP) during the midluteal period (P = 0.0161). As for the levels of bone resorption markers, urinary type I collagen C-telopeptide breakdown products (CTx) and free deoxypyridinoline (D-Pyr) decreased significantly during the early and midfollicular periods, urinary free D-Pyr and serum pyridinoline cross-linked carboxyl-terminal telopeptide of type I collagen (ICTP) (P = 0.0440) increased significantly during the early luteal period, and urinary CTx, free D-Pyr, and serum ICTP decreased significantly during the late luteal period (P = 0.01700.0008). The serum PTH level was significantly higher during the follicular than the luteal period (P = 0.0132). Serum sIL-6R significantly correlated with urinary CTx (r = 0.190, P < 0.05) and serum ALP (r = 0.209, P < 0.05) and serum estradiol with intact osteocalcin (r = 0.309, P < 0.0005) and serum ALP (r = 0.181, P < 0.05). These observations strongly suggest that cyclic variations in the levels of bone formation and resorption markers and of a bone-resorbing cytokine may be modulated by cyclic changes in serum steroid hormones during the menstrual period. In addition, the specific days of biochemical events in the menstrual cycle are crucial for evaluating osteoclastic and osteoblastic activities in pre- and perimenopausal women or in women starting GnRH agonist therapy.
This article has been cited by other articles:
![]() |
M. ZAIDI, S. EPSTEIN, and K. FRIEND Modeling of Serum C-Telopeptide Levels with Daily and Monthly Oral Ibandronate in Humans Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 560 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Puder, S. Varga, M. Kraenzlin, C. De Geyter, U. Keller, and B. Muller Central Fat Excess in Polycystic Ovary Syndrome: Relation to Low-Grade Inflammation and Insulin Resistance J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6014 - 6021. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Blum, B. Muller, P. Huber, M. Kraenzlin, C. Schindler, C. De Geyter, U. Keller, and J. J. Puder Low-Grade Inflammation and Estimates of Insulin Resistance during the Menstrual Cycle in Lean and Overweight Women J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3230 - 3235. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Y. Liu, K. A. Hoey, K. L. Mielke, J. D. Veldhuis, and S. Khosla A Randomized Placebo-Controlled Trial of Short-Term Graded Transdermal Estradiol in Healthy Gonadotropin-Releasing Hormone Agonist-Suppressed Pre- and Postmenopausal Women: Effects on Serum Markers of Bone Turnover, Insulin-Like Growth Factor-I, and Osteoclastogenic Mediators J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 1953 - 1960. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Haruyama, K. Igarashi, S. Saeki, M. Otsuka-Isoya, H. Shinoda, and H. Mitani Estrous-cycle-dependent Variation in Orthodontic Tooth Movement J. Dent. Res., June 1, 2002; 81(6): 406 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Vesper, L. M. Demers, R. Eastell, P. Garnero, M. Kleerekoper, S. P. Robins, A. K. Srivastava, G. R. Warnick, N. B. Watts, and G. L. Myers Assessment and Recommendations on Factors Contributing to Preanalytical Variability of Urinary Pyridinoline and Deoxypyridinoline Clin. Chem., February 1, 2002; 48(2): 220 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Wangen, A. M. Duncan, B. E. Merz-Demlow, X. Xu, R. Marcus, W. R. Phipps, and M. S. Kurzer Effects of Soy Isoflavones on Markers of Bone Turnover in Premenopausal and Postmenopausal Women J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3043 - 3048. [Abstract] [Full Text] |
||||
![]() |
S. Longobardi, N. Keay, C. Ehrnborg, A. Cittadini, T. Rosén, R. Dall, M. A. Boroujerdi, E. E. Bassett, M. L. Healy, C. Pentecost, et al. Growth Hormone (GH) Effects on Bone and Collagen Turnover in Healthy Adults and Its Potential as a Marker of GH Abuse in Sports: A Double Blind, Placebo-Controlled Study J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1505 - 1512. [Abstract] [Full Text] |
||||
![]() |
A. Zittermann, I. Schwarz, K. Scheld, T. Sudhop, H. K. Berthold, K. von Bergmann, H. van der Ven, and P. Stehle Physiologic Fluctuations of Serum Estradiol Levels Influence Biochemical Markers of Bone Resorption in Young Women J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 95 - 101. [Abstract] [Full Text] |
||||
![]() |
M. Sarno, H. Powell, G. Tjersland, D. Schoendorfer, H. Harris, K. Adams, P. Ogata, and G. R. Warnick A Collection Method and High-Sensitivity Enzyme Immunoassay for Sweat Pyridinoline and Deoxypyridinoline Cross-Links Clin. Chem., September 1, 1999; 45(9): 1501 - 1509. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |